Literature DB >> 7497534

Sjögren's syndrome.

R Manthorpe1, L T Jacobsson.   

Abstract

The review describes the historical development and nomenclature of Sjögren's syndrome--primary and secondary. The strengths and weaknesses as well as similarities and dissimilarities for establishing the diagnosis of keratoconjunctivitis sicca and xerostomia used among the five most commonly classification criteria sets are focused upon in text and table. Validation of the different sets of criteria are performed. Primary and secondary disease activity markers and outcome measures as well as future research plans for improving diagnosis are dealt with.

Entities:  

Mesh:

Year:  1995        PMID: 7497534     DOI: 10.1016/s0950-3579(05)80254-7

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  3 in total

1.  Increased serum CA 19-9 antibodies in Sjögren's syndrome.

Authors:  R Safadi; M Ligumsky; E Goldin; Y Ilan; Y S Haviv; S Nusair
Journal:  Postgrad Med J       Date:  1998-09       Impact factor: 2.401

2.  Sjögren's syndrome: History, clinical and pathological features.

Authors:  A L Parke; W W Buchanan
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

3.  Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease.

Authors:  Ghada Abughanam; Osama A Elkashty; Younan Liu; Mohammed O Bakkar; Simon D Tran
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.